Dr. Mark Hull is a research scientist at the AIDS Research program at the B.C. Centre for Excellence in HIV/AIDS and a Clinical Assistant Professor in the AIDS Division in the Department of Medicine at the University of British Columbia. He is also a staff physician at St. Paul’s Hospital, and a physician at various clinics with Vancouver Coastal Health.
He received a Bachelor of Science in biochemistry from the University of Saskatchewan, and then moved on to complete his Medical Degree, also at the University of Saskatchewan. He obtained his master’s in health sciences with a focus on healthcare and epidemiology from the University of British Columbia.
Dr. Hull’s areas of focus include antiretroviral clinical trials in HIV, infectious diseases with specific regard to the methicillin resistant S. aureus, HIV/hepatitis C co-infection clinical trials, as well as epidemiology.
He was the principal investigator for CTN 248, a study that aims to measure the effectiveness of providing incentives as a strategy for increasing adherence to antiretroviral medication among drug users, as well as for CTN 254, which evaluates the ability of inflammation to serve as a predictor of HIV disease progression. He was also a contributing author to the CTN 2016 HIV/HCV Co-Infection Guidelines.